Related Experiment Videos
Late onset ornithine carbamoyl transferase deficiency in males
1Department of Child Health, Institute of Child Health, London.
Insights
Ornithine carbamoyl transferase deficiency (OTC) can present with varied symptoms in boys, mimicking other conditions. Early hyperammonaemia recognition improves patient outlook, despite potential mortality.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Ornithine carbamoyl transferase deficiency (OTC) is an X-linked urea cycle disorder.
- It leads to hyperammonaemia, causing significant neurological damage.
- Early diagnosis and management are crucial for patient outcomes.
Observation:
- Six male patients with OTC deficiency were studied, presenting from infancy to childhood.
- Symptoms showed considerable variability, including neurological, behavioral, and gastrointestinal issues.
- Two patients died, along with two likely affected male siblings.
Findings:
- The diverse presentation of OTC deficiency can initially mislead diagnosis.
- Hyperammonaemia is the key biochemical marker for this condition.
- Prompt identification of hyperammonaemia is critical for intervention.
Implications:
- Increased awareness of OTC deficiency's varied clinical signs is needed.
- Timely diagnosis and treatment can significantly improve the prognosis for affected individuals.
- Genetic counseling and carrier screening are important for at-risk families.
Abstract:
Six boys with ornithine carbamoyl transferase deficiency presenting in infancy or later childhood are described. There was wide variation in both the time of presentation and the symptoms, which may initially suggest a neurological, behavioural, or gastroenterological problem. Two patients died, as did two male siblings who were probably affected, but with early recognition of the hyperammonaemia the outlook is good.